Medicx Fund Regulatory News (MXF)

For immediate release 1 October 2014

MedicX Fund Limited

("MedicX Fund", the "Fund" or the "Company")

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 30 September 2014 was 354,389,088 (excluding treasury shares) with each share holding one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

The Company also holds 7,056,692 ordinary shares in treasury.

End

For further information please contact:

MedicX Fund +44 (0) 1481 723 450

David Staples, Chairman

MedicX Group +44 (0) 1483 869 500

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity Limited +44 (0) 20 7523 8000

Andrew Zychowski /Helen Goldsmith

Buchanan Communications +44 (0) 20 7466 5000

Charles Ryland/Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 136 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.